Metabolic syndrome and urinary stone composition: what factors matter most?

Loyola University Medical Center, Department of Urology, Fahey Center, Maywood, IL. Electronic address: .
Urology (Impact Factor: 2.42). 07/2012; 80(4):805-10. DOI: 10.1016/j.urology.2012.05.011
Source: PubMed

ABSTRACT To determine which metabolic syndrome (MetS) factors lead to differences in stone composition in a multivariate analysis.
We retrospectively reviewed medical charts of patients who had a kidney stone removed over a 5-year period (2006-2011). MetS factors (obesity [body mass index {BMI} >30], diabetes mellitus [DM], hypertension [HTN], and dyslipidemia [DLD]) were tallied in each patient. For the latter 3 factors, medical treatment for the condition was used to tag a patient with the condition. Stone composition was determined by the dominant (>50%) component. Statistical analysis was designed to determine which MetS factors were independently associated with differences in stone composition.
Five hundred ninety kidney stones were included in the analysis. Patients with MetS had a higher prevalence of uric acid stones and lower prevalence of calcium phosphate stones. HTN and DM were independently associated with differences in composition, specifically uric acid stones (higher proportion), and calcium phosphate stones (lower proportion). Obesity was not associated with differences in composition, although a secondary analysis of morbidly obese patients showed a higher proportion of uric acid stones and a lower proportion of calcium oxalate stones.
HTN and DM are the MetS factors independently associated with differences in stone composition, specifically the uric acid and calcium phosphate components. Obesity has little effect on stone composition until a very high (>40) BMI is reached. The overall effect of MetS factors on stone type is relatively small, because most stones are calcium oxalate and MetS factors have little impact on calcium oxalate frequency.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Metabolic syndrome has been implicated in the pathogenesis of uric acid stones. Although not completely understood, its role is supported by many studies demonstrating increased prevalence of uric acid stones in patients with metabolic syndrome and in particular insulin resistance, a major component of metabolic syndrome. This review presents epidemiologic studies demonstrating the association between metabolic syndrome and nephrolithiasis in general as well as the relationship between insulin resistance and uric acid stone formation, in particular. We also review studies that explore the pathophysiologic relationship between insulin resistance and uric acid nephrolithiasis.
    World journal of nephrology. 11/2014; 3(4):237-42.
  • [Show abstract] [Hide abstract]
    ABSTRACT: URAT1 and GLUT9 are two primary urate transporters involved in the renal urate handling. Renal urate underexcretion was reported in uric acid stone formers (UASF) in previous clinical studies. The aim of this study was to investigate the clinical features and possible impact of protein expression of URAT1 and GLUT9 in renal tissues of patients with uric acid (UA) nephrolithiasis. 23 UASF, 27 patients with calcium oxalate (CaOx) stones, and 22 normal controls were enrolled in this study. Clinical data revealed that older age of onset, high plasma UA concentration, low urinary PH, and relative renal urate underexcretion were associated with UASF. By immunohistochemical or western blotting analysis, a significant increase in the relative expression quantity of URAT1 in renal tissue of UASF was found compared to patients with CaOx nephrolithiasis and normal controls. In conclusion, our results suggested that upregulated URAT1 protein expression might contribute to the relative urate underexcretion from the kidney of UASF.
    Cell biochemistry and biophysics 04/2014; · 3.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the relationship between body mass index (BMI), visceral adipose tissue (VAT), and stone components. A cross-sectional study has been done for urinary stone cohort between 2010 and 2012. Data on patient's age, gender, BMI, urinary pH, stone components, and VAT using computed tomography-based delineation were collected. Obesity was defined as BMI ≥ 25 kg/m(2) or as VAT ≥ 100 cm(2). To compare the differences between the types of stones, multinomial logistic regression analyses were conducted. Of 203 cases, 49.3% patients were obese based on BMI, and 65.5% were obese using VAT criteria. Multinomial logistic regression analysis revealed that obesity defined by VAT was found to be associated with uric acid stones compared with calcium phosphate stones (odds ratio [OR] 6.544, 95% confidence interval [CI], P = .030) and mixed calcium oxalate phosphate stones (OR 5.582, 95% CI, P = .038). Similar results were observed in calcium oxalate stones over calcium phosphate stones (OR 2.984, 95% CI, P = .032) and calcium oxalate phosphate stones (OR 2.542, 95% CI, P = .041). On the contrary, obesity defined based on BMI has no correlation over all types of urinary stone components. This result implies that VAT has a more important role in uric acid and calcium oxalate stone formation than total body fat, represented by BMI.
    Urology 04/2014; · 2.42 Impact Factor

Similar Publications